BioCentury
ARTICLE | Company News

Alpine Biosciences, Oncothyreon deal

September 15, 2014 7:00 AM UTC

Oncothyreon acquired drug delivery company Alpine for 9.2 million Oncothyreon shares, or about $27.1 million based on Oncothyreon's close of $2.93 on Aug. 8, before the deal was announced. Alpine is d...